Martingale Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.29M | Buy |
|
|||||
|
2025
Q1 | $2M | Buy |
|
|||||
|
2024
Q4 | $1.94M | Buy |
|
|||||
|
2024
Q3 | $1.78M | Sell |
|
|||||
|
2024
Q2 | $1.69M | Sell |
|
|||||
|
2024
Q1 | $2.32M | Sell |
|
|||||
|
2023
Q4 | $2.28M | Sell |
|
|||||
|
2023
Q3 | $1.92M | Buy |
|
|||||
|
2023
Q2 | $2.04M | Buy |
|
|||||
|
2023
Q1 | $875K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $554K | Sell |
|
|||||
|
2018
Q4 | $2.17M | Sell |
|
|||||
|
2018
Q3 | $4.48M | Buy |
|
|||||
|
2018
Q2 | $3.38M | Hold |
|
|||||
|
2018
Q1 | $2.69M | Sell |
|
|||||
|
2017
Q4 | $2.26M | Buy |
|
|||||
|
2017
Q3 | $1.03M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $531K | Buy |
|